Avanos Medical, Inc. (AVNS)

Avanos Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-62.2	-61.8	50.5	6.3	-29	-45.9
Depreciation & Amortization	45.4	46.1	47.7	38.3	42.9	36.9
Share-Based Compensation	15.4	15.8	15.9	13.2	12.1	10.5
Other Operating Activities	32.6	32.3	-23.2	29.5	-28.5	-76
Operating Cash Flow	31.2	32.4	90.9	87.3	-2.5	-74.5
Operating Cash Flow Growth	-62.09%	-64.36%	4.12%	-	-	-
Capital Expenditures	-17.9	-17.8	-19.3	-21	-20.2	-50.6
Acquisitions	41.5	39.4	-116.1	0	-4	-57.5
Investing Cash Flow	23.6	21.6	-135.4	-21	-24.2	-108.1
Share Issuance / Repurchase	-25.9	-17.8	-43.8	-5.3	2.5	1.7
Debt Issued / Paid	-34.7	-64.7	100.5	-50	-69.8	-0.2
Other Financing Activities	-12.2	-11.7	-	-	-2.7	-
Financing Cash Flow	-72.8	-94.2	56.7	-55.3	-70	1.5
Exchange Rate Effect	-1.9	0.2	-3	-4	2.9	1.9
Net Cash Flow	-19.9	-40	9.2	7	-93.8	-179.2
Free Cash Flow	13.3	14.6	71.6	66.3	-22.7	-125.1
Free Cash Flow Growth	-79.22%	-79.61%	7.99%	-	-	-
Free Cash Flow Margin	1.96%	2.17%	10.47%	11.29%	-3.18%	-17.93%
Free Cash Flow Per Share	0.29	0.31	1.54	1.38	-0.47	-2.61

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).